World-renowned oncologist Dr. Bicher, specializes in hyperthermia cancer treatment. One of the founding doctors of this alternative procedure, Dr. Bicher directs the Bicher Cancer Institute (formerly Valley Cancer Institute), one of the largest hyperthermic cancer treatment centers in the country. Under this treatment, hyperthermia machines heat cancerous tumors to approximately 104 degrees Fahrenheit, increasing blood circulation and oxygenation of the cancer cells within the tumor and making them more susceptible to radiation treatment destruction. After the Hyperthermia treatment application, patients undergo low-dose radiation therapy to help destroy the tumor even further, ultimately deteriorating its presence in the body. Using this procedure, typically treats up to 56 patients per day at the clinic.
Since 1984, he has healed many patients worldwide using this FDA-approved treatment. Using Intensity-Modulated Radiation Therapy, he combines hyperthermia with low-dose, pinpointed radiation. Because the treatment focuses solely on the tumor itself, it decreases the likelihood of damage to healthy tissue within the body and the side effects are minimum comparing with conventional cancer therapies.
Dr. Haim Bicher remains committed to improving his patients’ chances of survival and preserving their quality of life as much as possible by addressing their afflictions with alternative means of treatment. Coupled with low-dose radiation, the painless hyperthermia procedure decreases hair loss, weakness, sexual side effects, and compromised immune systems that typically result from chemotherapy and traditional radiation treatments. Hyperthermia also significantly reduce pain on situations where it is present, and reduce and eliminate the use of pain killers.
He has studied blood circulation within cancerous tumors under the direction of Nobel Prize Laureate Dr. B. A. Houssay at Hadassah Medical School in Jerusalem, Israel. Upon graduation, he served with the National Committee on Hyperthermia, the North American Hyperthermia Group, the International Society on Oxygen Transport of Tissue, and the American Society of Clinical Hyperthermic Oncology. He has received the Zondec Award while in medical school, along with several travel awards and specialized trips to study within his field. James Bicher, MD, currently holds memberships with the American Medical Association, Society for Thermal Medicine, American Society of Clinical Oncology, and the International Clinical Hyperthermia Society.
Dr Haim Bicher is currently in Tbilisi, Georgia, for the XXX International Clinical Hyperthermia Society annual meeting, where he is presenting this scientific paper: Therapeutic Advantage of Hyperfractionated Thermoradiotherapy (HTRT) Over Conventional Radiation In Superficial Tumors Treated De Novo With Curative Intent, which in regular language means "Hyperthermia plus Low-Dose-Radiation treatment advantage over conventional cancer treatment and with curative intent"